Published in J Hypertens Suppl on December 01, 1984
Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load. J Am Soc Nephrol (2008) 1.68
Erythrocyte concentrations and transmembrane fluxes of sodium and potassium in essential hypertension: role of intrinsic and environmental factors. Cardiovasc Drugs Ther (1990) 0.75
Recommendations for human blood pressure determination by sphygmomanometers. Circulation (1967) 6.57
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med (1993) 6.45
Salt, volume and the prevention of hypertension. Circulation (1976) 2.65
Partial reduction of blood pressure and prevention of complications in hypertension. N Engl J Med (1974) 2.21
Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch Intern Med (1988) 2.13
Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Circulation (1980) 1.90
Metabolically linked vasoactive chemicals in local regulation of blood flow. Physiol Rev (1968) 1.61
Informed consent: how much does the patient understand? Clin Pharmacol Ther (1980) 1.50
cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc Natl Acad Sci U S A (1993) 1.50
The role of humoral agents in volume expanded hypertension. Life Sci (1976) 1.47
Effects of MK-870 in normal subjects and hypertensive patients. N Engl J Med (1966) 1.45
Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol (1984) 1.43
Thiazide diuretics: how real are the concerns? Hosp Pract (Off Ed) (1990) 1.39
Local effects of O2 and CO2 on limb, renal, and coronary vascular resistances. Am J Physiol (1967) 1.34
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med (1999) 1.24
THE ACCELERATION OF LINEAR FLOW IN THE DEEP VEINS OF THE LOWER EXTREMITY OF MAN BY LOCAL COMPRESSION. J Clin Invest (1949) 1.23
Persistence of normal BP after withdrawal of drug treatment in mild hypertension. Arch Intern Med (1982) 1.18
Age, race, sex and other indices of risk in hypertension. Am J Med (1973) 1.17
Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system. Am J Med (1983) 1.17
Sounding board. Should mild hypertension be treated? N Engl J Med (1982) 1.13
Resistance responses to local changes in plasma osmolality in three vascular beds. Am J Physiol (1971) 1.11
Hemodynamic changes during sleep. J Appl Physiol (1967) 1.11
The cardiovascular risks of thiazide diuretics. Clin Pharmacol Ther (1986) 1.10
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs. Am J Cardiol (1973) 1.10
Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulation and reactive hyperemia. Pflugers Arch (1977) 1.10
Long-term ouabain administration produces hypertension in rats. Hypertension (1993) 1.09
The Veterans Administration cooperative study on antihypertensive agents. Implications for stroke prevention. Stroke (1974) 1.07
Influence of the adrenergic system in renovascular hypertension. Cardiovasc Res (1971) 1.05
Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Hypertension (1982) 1.05
The mechanism of the vasodilator action of potassium. Proc Soc Exp Biol Med (1972) 1.05
Metabolic factors in peripheral circulatory regulation. Fed Proc (1975) 1.05
Effect of osmolarity on canine renal vascular resistance. Am J Physiol (1969) 1.04
The chemotherapy of hypertension. JAMA (1971) 1.03
Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med (1995) 1.03
Coronary responses to dilating substances and competitive inhibition by theophylline in the isolated perfused guinea pig heart. Pflugers Arch (1975) 1.02
Arterial pulse waves and velocity and systolic time intervals in diabetic children. Am Heart J (1974) 1.01
Effects of three sodium-potassium adenosine triphosphatase inhibitors. Hypertension (1991) 1.01
Alteration of the course of hypertension in the spontaneously hypertensive rat. Circ Res (1972) 1.01
Potassium effects on contraction in arterial smooth muscle mediated by Na+, K+-ATPase. Fed Proc (1983) 1.00
Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J Neurochem (1994) 0.99
Reduction of exercise dilation by theophylline. Proc Soc Exp Biol Med (1977) 0.99
Interaction of O2 and CO2 in sustained exercise hyperemia of canine skeletal muscle. Am J Physiol (1975) 0.98
Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med (1980) 0.98
An isolated guinea pig heart preparation with in vivo like features. Pflugers Arch (1975) 0.98
Composition of canine renal hilar lymph. Am J Physiol (1965) 0.97
Physiology and pharmacology of the coronary circulation and myocardium, particularly in relation to coronary artery disease. Am J Med (1969) 0.97
Role of dietary salt in hypertension. J Am Coll Nutr (1995) 0.96
Role of osmolarity, K+, H+, Mg++, and O2 in local blood flow regulation. Am J Physiol (1970) 0.95
Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias. Am J Cardiol (1983) 0.95
Long-term effect of probenecid on diuretic-induced hyperuricemia. JAMA (1966) 0.95
The clinical spectrum of essential hypertension. Arch Intern Med (1974) 0.95
Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem (1995) 0.94
Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J (1978) 0.93
Hemodynamic changes during sleep in hypertensive patients. Circulation (1969) 0.93
Salt in hypertension and the effects of diuretics. Annu Rev Pharmacol Toxicol (1979) 0.92
Mechanisms of edema formation by histamine administered locally into canine forelimbs. Am J Physiol (1972) 0.92
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. Clin Cardiol (1994) 0.92
Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension. Am J Cardiol (1985) 0.92
Antagonism of histamine edema formation by catecholamines. Am J Physiol (1978) 0.91
The veterans trial and sequelae. Br J Clin Pharmacol (1982) 0.91
Direct and reflex cardiostimulating effects of hydralazine. Am J Cardiol (1977) 0.91
Humoral factors and the sodium-potassium pump in volume expanded hypertension. Life Sci (1979) 0.91
Adenosine, theophylline, and perfusate pH in the isolated, perfused guinea pig heart. Circ Res (1978) 0.90
Effectiveness of potassium chloride or triamterene in thiazide hypokalemia. Arch Intern Med (1985) 0.90
Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med (1983) 0.90
Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol. Circulation (1973) 0.90
Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. J Lab Clin Med (1984) 0.90
Relationships between adenosine and coronary resistance in conscious exercising dogs. Am J Physiol (1982) 0.89
Hypertension and atherosclerosis. Am J Med (1969) 0.89
Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension (1990) 0.89
Partial versus complete control of blood pressure in the prevention of hypertensive complications. Circ Res (1975) 0.89
Changes in dog gracilis muscle adenosine during exercise and acetate infusion. Am J Physiol (1983) 0.88
Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent. JAMA (1977) 0.88
The role of a humoral sodium-potassium pump inhibitor in low-renin hypertension. Fed Proc (1983) 0.88
Effects of diuretic therapy and exercise-related arrhythmias in systemic hypertension. Am J Cardiol (1989) 0.87
Effects of chemical carcinogens on neoplastic transformation and morphology of cells in culture. J Natl Cancer Inst (1974) 0.87
Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res (1976) 0.87
Effects of rat atrial extract on sodium transport and blood pressure in the rat. Proc Soc Exp Biol Med (1984) 0.87
Effect of norepinephrine on lymph flow and edema formation in the canine forelimb. Am J Physiol (1982) 0.87
Effect of treatment on morbidity in hypertension. Veterans Administration Cooperative Study on Antihypertensive Agents. Effect on the electrocardiogram. Circulation (1973) 0.86
Humoral Na+-K+ pump inhibitory activity in essential hypertension and in normotensive subjects after acute volume expansion. Am J Hypertens (1989) 0.86
Effect of cardiac rhythm on vena caval blood flows. Am J Physiol (1966) 0.86
Utilization of selected leucine peptide amides by Escherichia coli. J Bacteriol (1975) 0.86
Peripheral vascular resistance. Annu Rev Med (1968) 0.85
Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem (1995) 0.85
Attenuated vasodilator responses to K+ in essential hypertensive men. J Clin Invest (1974) 0.84
Reflex vascular responses in kidney, ileum, and forelimb to carotid body stimulation. Am J Physiol (1975) 0.84
Leukocyte intracellular cations in hypertension: Effect of antihypertensive drugs. Am Heart J (1978) 0.84
Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study. Hypertension (1990) 0.84
Potassium and blood vessels. Life Sci (1975) 0.84
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol. J Clin Hypertens (1986) 0.84